Search | RISE

Displaying 18 hits

Stories X Life Science X

Search with filter Search with filter Hide filter

18 hits

Grid

List

Visualization for more effective care

Sometimes, the data in patient records is presented in a graph, or a district nurse remotely monitors patients being cared for in the home. Both are examples of how health data can be visualized so that healthcare professionals ca…

Financing of long-term social investments

Because social investments in society are long-term in nature and typically involve many parties, the municipalities and regions in Sweden tend to have a hard time putting them into practice. The public sector also needs to become…

Innovative solutions minimise healthcare-associated infections

The problem of healthcare-associated infections and antibiotic resistance risks putting advanced care as we know it at risk. Through innovative solutions aimed at stopping the spread of infection, RISE works together with Sahlgren…

From sick care to health care – the future of drug development

Today’s pharmaceutical development is not only about pills, but the patient’s overall health, including diagnostics, treatment, regulatory compliance and aftercare. This sets entirely new demands on innovation and cross-fertilisat…

Digital platform provides guidance for mental health

In times of increased stress and uncertainty, many people are looking for advice and guidance to feel better. There are currently hundreds of thousands of health apps available to download, but the quality varies and the huge rang…

Sweden takes the lead within ATMP

According to Vinnova’s Vision-driven Health programme, Sweden shall be a leader in the field of advanced therapies by 2030, i.e. medicines based on gene, cell and tissue therapy products. The five-year initiative aimed at achievin…

Individualised organs to be tested in patients

There is a lot of global interest in Advanced Therapy Medicinal Products (ATMP). These products involve regenerative medicine, such as therapies targeting cells, genes, and tissues, all of which build or replace organs in the body…

Antiviral spray reduces infection risk from public surfaces

Contaminated surfaces in public areas contribute to the spread of viruses, such as the coronavirus. RISE, in collaboration with Trion Tensid, is developing an antiviral formulation that can be sprayed on public surfaces to re…

3D structures facilitate the development of new cancer medicines

The human body is complex. Only five percent of cancer drugs used in clinical trials, that is, tested on patients, result in approved products. RISE develops new testing systems, and one of these involves 3D structures to improve …

How social impact bonds can stimulate preventative measures

There is no shortage of interest in and opinions regarding social investment and social impact bonds (SIBs). At RISE, a knowledge centre is currently being developed to assist and support the public sector with innovation and deve…

Support for healthcare during the crisis

Within RISE, there is cutting-edge expertise that can serve as support for healthcare and its suppliers during the current crisis. We can offer support and advice in, among other things, drug production and drug development, medic…

New drug for hereditary eye diseases

Hereditary retinal disease is the most common cause of serious vision impairment among people of working age. There are currently around 5,000 people in Sweden with this type of disease and worldwide, approximately 1 out of every …

Next Last

Page 1 of 2